People with breast cancer and lymphoma who experience cognitive side effects associated with cancer treatment may be able to alleviate their symptoms by taking statins, which are common meds used to ...

The Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, has announced a $78 million gift for cancer research, treatment and patient care at the top-ranked Dana-Farber ...

Here's a list of the approved drugs to treat multiple myeloma. Click on any of the medications for more info on indications, dosing and side effects.

People who are overweight or obese are at higher risk for at least 13 different types of cancer, which together make up about 40 percent of all cancer diagnoses in the United States, according to the ...

Anxiety about scans, bloodwork and similar tests is a common experience for many people living with and beyond cancer, but they are finding creative ways to ease its grip.

According to Stat, the documents included in presentations made in June and July 2017 strongly criticized the Watson for Oncology system, a cognitive computing system trained by doctors to help choose ...

Researchers at Johns Hopkins University have found that people who engage in oral sex have an 80% higher risk of developing mouth and throat (oropharyngeal) cancers. The risk was particularly high for ...

Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018.

Cholangiocarcinoma, a rare type of cancer diagnosed in about 2,000 to 3,000 people each year in the United States, originates in bile ducts, which are part of a network of tubes inside and outside the ...

Led by experts at University of Colorado Cancer Center, the endoscopy research includes data from over 15,000 patients. November 4, 2025 • By University of Colorado Cancer Center and Mark Harden ...

Datroway, from AstraZeneca and Daiichi Sankyo, is a novel antibody-drug conjugate. It consists of an antibody that targets TROP-2 and delivers a topoisomerase inhibitor chemotherapy payload directly ...

On December 15, the Food and Drug Administration (FDA) approved Padcev (enfortumab vedotin) plus Keytruda (pembrolizumab) for people with locally advanced or metastatic urothelial cancer, which ...